{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:57:48Z","timestamp":1793642268722,"version":"4.5.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofpsychiatricresearch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jpsychires.2016.07.007","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T17:41:47Z","timestamp":1468086107000},"page":"133-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis"],"prefix":"10.1016","volume":"81","author":[{"given":"Francesco","family":"Bartoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Crocamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Gennaro","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carr\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2016.07.007_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tins.2008.10.001","article-title":"Purinergic signalling in the nervous system: an overview","volume":"32","author":"Abbracchio","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-5618.2006.00363.x","article-title":"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial","volume":"8","author":"Akhondzadeh","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jad.2014.11.005","article-title":"Increased uric acid levels in bipolar disorder subjects during different phases of illness","volume":"173","author":"Albert","year":"2015","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib4","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.2013.13040447","article-title":"Bipolar disorder, schizophrenia, and metabolic syndrome","volume":"170","author":"Bartoli","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jpsychores.2016.03.014","article-title":"Exploring the association between bipolar disorder and uric acid: a mediation analysis","volume":"84","author":"Bartoli","year":"2016","journal-title":"J.\u00a0Psychosom. Res."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jad.2015.03.041","article-title":"Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder","volume":"179","author":"Bortolasci","year":"2015","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/pr.58.1.5","article-title":"Pathophysiology and therapeutic potential of purinergic signalling","volume":"58","author":"Burnstock","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission","volume":"87","author":"Burnstock","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","article-title":"Purinergic signalling and disorders of the central nervous system","volume":"7","author":"Burnstock","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00127-014-0835-y","article-title":"The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis","volume":"49","author":"Carr\u00e0","year":"2014","journal-title":"Soc. Psychiatry. Psychiatr. Epidemiol."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/JCP.0b013e3182664e64","article-title":"The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder","volume":"32","author":"Chiu","year":"2012","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib13","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib14","first-page":"195","article-title":"Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder","volume":"22","author":"De Berardis","year":"2008","journal-title":"J.\u00a0Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1758-5996-4-12","article-title":"High plasma uric acid concentration: causes and consequences","volume":"4","author":"de Oliveira","year":"2012","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib17","first-page":"315","article-title":"TBARs and non-enzymatic antioxidant parameters in Tunisian bipolar I patients","volume":"27","author":"Ezzaher","year":"2012","journal-title":"Immuno Anal. Biol. Spec."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2165\/00023210-200822080-00004","article-title":"Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden","volume":"22","author":"Fagiolini","year":"2008","journal-title":"CNS drugs"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.schres.2015.07.047","article-title":"Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: results from the FACE-SZ cohort","volume":"168","author":"Godin","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib20","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.2174\/1381612811319130011","article-title":"Chronic hyperuricemia, uric acid deposit and cardiovascular risk","volume":"19","author":"Grassi","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib21","first-page":"229","article-title":"Are uric acid levels different from healthy subjects in bipolar affective disorder and schizophrenia?: relationship between clinical improvement and episode severity in male patients","volume":"51","author":"Gultekin","year":"2014","journal-title":"Noropsikiyatri Ars."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2013.06.038","article-title":"Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators","volume":"149","author":"Hirota","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib24","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.euroneuro.2014.05.013","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder","volume":"24","author":"Jahangard","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib25","first-page":"981","article-title":"Increased uric acid levels in bipolar disorder: is it trait or state?","volume":"27","author":"Kesebir","year":"2013","journal-title":"J.\u00a0Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2014.04.053","article-title":"Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder: the role of affective temperament","volume":"165","author":"Kesebir","year":"2014","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib27","article-title":"Serum uric acid levels in different phases of acute severe manic and depressed patients","author":"Keshavarz","year":"2016","journal-title":"Arch. Neurosci."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4306\/jknpa.2016.55.1.25","article-title":"The correlation between clinical symptoms, serum uric acid level and EEG in patient with bipolar I disorder","volume":"55","author":"Kim","year":"2016","journal-title":"J.\u00a0Korean Neuropsychiatr. Assoc."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2015.10.032","article-title":"Purinergic receptors in psychiatric disorders","volume":"104","author":"Krugel","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1566524015666150330163724","article-title":"Purinergic signaling and energy homeostasis in psychiatric disorders","volume":"15","author":"Lindberg","year":"2015","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2009.05.023","article-title":"Association of serum uric acid levels with emotional and affective temperaments","volume":"121","author":"Lorenzi","year":"2010","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/JCP.0b013e318268391d","article-title":"Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania","volume":"32","author":"Machado-Vieira","year":"2012","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00004714-200112000-00017","article-title":"Therapeutic efficacy of allopurinol in mania associated with hyperuricemia","volume":"21","author":"Machado-Vieira","year":"2001","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/mehy.2001.1543","article-title":"Purinergic dysfunction in mania: an integrative model","volume":"58","author":"Machado-Vieira","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib36","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A\u00a0double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2010.04.012","article-title":"Bipolar disorder and metabolic syndrome: an international perspective","volume":"126","author":"McIntyre","year":"2010","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.psychres.2014.11.038","article-title":"Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium","volume":"225","author":"Muti","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pnpbp.2014.10.016","article-title":"Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics","volume":"57","author":"Ortiz","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib42","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/ije\/dyn065","article-title":"Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation","volume":"37","author":"Patsopoulos","year":"2008","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.pnpbp.2010.02.027","article-title":"Increased uric acid levels in drug-naive subjects with bipolar disorder during a first manic episode","volume":"34","author":"Salvadore","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib44","series-title":"Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series","article-title":"Addressing reporting biases","author":"Sterne","year":"2008"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib45","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clinbiochem.2011.10.010","article-title":"Serum uric acid levels and the clinical characteristics of depression","volume":"45","author":"Wen","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jpsychires.2016.07.007_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eurpsy.2013.05.006","article-title":"Gender-based differences in oxidative stress parameters do not underlie the differences in mood disorders susceptibility between sexes","volume":"29","author":"Wiener","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.07.007_bib48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/msj.20042","article-title":"Bipolar disorder: candidate drug targets","volume":"75","author":"Zarate","year":"2008","journal-title":"Mt. Sinai J. Med."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616301364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616301364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T05:06:56Z","timestamp":1718687216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395616301364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":47,"alternative-id":["S0022395616301364"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2016.07.007","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2016.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}